In mouse models of experimental autoimmune encephalomyelitis (EAE) and asthma, the lack of Act1 leads to resistance to IL-17-mediated inflammation (Qian et al., 2007; Kang et al., 2010). This evidence concerns the gene TRAF3IP2 and experimental autoimmune encephalomyelitis.